|
Q4 FY2026
As of Jun 28, 2026
|
Q3 FY2026
As of Mar 29, 2026
|
Q2 FY2026
As of Dec 28, 2025
|
Q1 FY2026
As of Sep 28, 2025
|
Q4 FY2025
As of Jun 29, 2025
|
Q3 FY2025
As of Mar 30, 2025
|
Q2 FY2025
As of Dec 29, 2024
|
Q1 FY2025
As of Sep 29, 2024
|
Q4 FY2024
As of Jun 30, 2024
|
Q3 FY2024
As of Mar 31, 2024
|
Q2 FY2024
As of Dec 31, 2023
|
Q1 FY2024
As of Sep 24, 2023
|
Q4 FY2023
As of Jun 25, 2023
|
Q3 FY2023
As of Mar 26, 2023
|
Q2 FY2023
As of Dec 25, 2022
|
Q1 FY2023
As of Sep 25, 2022
|
Q4 FY2022
As of Jun 26, 2022
|
Q3 FY2022
As of Mar 27, 2022
|
Q2 FY2022
As of Dec 26, 2021
|
Q1 FY2022
As of Sep 26, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Short-term investments | ||||||||||||||||||||
| Total cash, cash equivalents and short-term investments | ||||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||||
| Inventories, net | ||||||||||||||||||||
| Income taxes receivable | ||||||||||||||||||||
| Investment tax credit receivable | ||||||||||||||||||||
| Prepaid expenses | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Current assets held for sale from discontinued operations | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Long-term receivables | ||||||||||||||||||||
| Other long-term investments | ||||||||||||||||||||
| Deferred tax assets | ||||||||||||||||||||
| Investment tax credit receivable | ||||||||||||||||||||
| Long-term investment tax credit receivable | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Long-term assets held for sale from discontinued operations | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and Stockholders' Equity | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable and accrued expenses | ||||||||||||||||||||
| Contract liabilities and distributor-related reserves | ||||||||||||||||||||
| Income taxes payable | ||||||||||||||||||||
| Finance lease liabilities | ||||||||||||||||||||
| Current maturity on long-term borrowings | ||||||||||||||||||||
| Other current liabilities | ||||||||||||||||||||
| Current liabilities held for sale from discontinued operations | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term liabilities: | ||||||||||||||||||||
| Long-term debt | ||||||||||||||||||||
| Convertible notes, net | ||||||||||||||||||||
| Deferred tax liabilities | ||||||||||||||||||||
| Finance lease liabilities - long-term | ||||||||||||||||||||
| Other long-term liabilities | ||||||||||||||||||||
| Long-term liabilities held for sale from discontinued operations | ||||||||||||||||||||
| Total long-term liabilities | ||||||||||||||||||||
| Liabilities subject to compromise | ||||||||||||||||||||
| Forward equity contract | ||||||||||||||||||||
| Long-term warrant | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders’ equity: | ||||||||||||||||||||
| Preferred stock, par value $0.00125 and $0.01; 100,000 and 3,000 shares authorized at June 28, 2026 and June 29, 2025; none issued and outstanding | ||||||||||||||||||||
| Common stock, par value $0.00125; 350,000 shares authorized at June 28, 2026 and 400,000 shares authorized at June 29, 2025; 52,162 and 155,643 shares issued and outstanding at June 28, 2026 and June 29, 2025, respectively | ||||||||||||||||||||
| Additional paid-in-capital | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total stockholders' equity (deficit) | ||||||||||||||||||||
| Total liabilities and stockholders’ equity (deficit) | ||||||||||||||||||||
Loading...
